PLK1 and breast cancer: GSK461364 is thiophene amide, an ATP-competitor PLK1 inhibitor, which promotes G2/M arrest in tumor tissues (151); in addition, the drug enhanced the radio sensitivity of breast cancer cells in vivo (90).